Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
1 other identifier
interventional
1,000
1 country
1
Brief Summary
This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB# 100221MP2A), the purpose of which is to improve cardiometabolic health in two uniquely comparable cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves separate but related projects that aim to improve cardiometabolic health outcomes through better risk factor control for three chronic conditions that are of tremendous public health importance, (hypertension (HTN), heart failure, and coronary heart disease), all of which contribute significantly to premature death in Detroit and Cleveland. The present study is the prospective observational cohort component of ACHIEVE P1- EPI (Project 1) of the ACHIEVE GREATER Center and serves to characterize the population of patients with blood pressure (BP) levels above normal attending The Wayne Health Mobile Health Unit (MHU) events to better understand key factors (e.g., social determinants of health) that convey information about baseline BP levels and related clinical outcomes (e.g., follow-up clinic visits, BP control, and cardiovascular events).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jun 2025
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
June 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
July 15, 2025
July 1, 2025
2 years
July 30, 2024
July 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measure Blood Pressure Protocol Fidelity
Achieve a minimum of six (6) measurements of two (2) or more readings of systolic and diastolic blood pressures at baseline, Month 6 and Month 11 within a seven (7) day period.
12 Months
Study Arms (2)
Text Message
EXPERIMENTALParticipants assigned to the interventional group will receive a text message reminding them to take their blood pressure.
Control/No Text Message
NO INTERVENTIONThose assigned to the usual care group will not receive a reminder text message.
Interventions
Randomized selection of recruited participants that will receive text messages reminding them to take their blood pressure.
Eligibility Criteria
You may qualify if:
- Mobile Health Unit Patients with blood pressure above normal (≥120 systolic and/or ≥80 mmHg)
- Has a phone with the ability to receive text messages
- + years old
- Consent to allow prospective follow-up including through EHR review
You may not qualify if:
- Non-mobile health unit patients
- MHU patients with systolic BP \< 120 mmHg AND diastolic BP \< 80 mmHg
- Pregnant Women
- Children less than 18 years old
- Individuals viewed by the investigative team as unable to understand and sign the informed consent form
- Currently enrolled in another on-going interventional trial initiated on the mobile health unit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wayne Health Mobile Units
Detroit, Michigan, 48201, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven J Korzeniewski, PhD
Wayne State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Assistant Vice President for Translational Sciences and Clinical Research Innovation
Study Record Dates
First Submitted
July 30, 2024
First Posted
September 19, 2024
Study Start
June 11, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
July 15, 2025
Record last verified: 2025-07